Champions Oncology (CSBR) Other Operating Expenses (2010 - 2026)

Champions Oncology's Other Operating Expenses history runs 17 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 37.59% year-over-year to $11.6 million; the TTM figure through Jan 2026 stood at $40.6 million (up 13.34% YoY), while the FY2025 annual figure was $36.2 million, down 1.82% from the prior year.
• Other Operating Expenses was $11.6 million for Q1 2026 at Champions Oncology, up from $9.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $11.6 million in Q1 2026 to a low of $7.8 million in Q2 2022.
• Historically, Other Operating Expenses has averaged $9.2 million across 5 years, with a median of $9.3 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses decreased 12.68% in 2025, then surged 37.59% in 2026.
• A 5-year view of Other Operating Expenses shows it stood at $9.1 million in 2022, then declined by 7.98% to $8.4 million in 2023, then climbed by 9.1% to $9.2 million in 2024, then climbed by 0.88% to $9.3 million in 2025, then increased by 25.15% to $11.6 million in 2026.
• The last three Other Operating Expenses figures came in at $11.6 million (Q1 2026), $9.3 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.